Reports for TEVA CANADA LIMITED
Formerly known as ACTAVIS PHARMA COMPANY
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
103 (48%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FOSINOPRIL | 20MG | TABLET | Resolved | 2024-03-18 | 2024-04-05 | 222563 |
| TEVA-FOSINOPRIL | 10MG | TABLET | Resolved | 2017-08-21 | 2017-09-19 | 19955 |
| TEVA-FOSINOPRIL | 20MG | TABLET | Resolved | 2023-07-05 | 2023-07-21 | 197539 |
| TEVA-FULVESTRANT INJECTION | 50MG | SOLUTION | Resolved | 2020-04-02 | 2020-05-01 | 110691 |
| TEVA-FULVESTRANT INJECTION | 50MG | SOLUTION | Resolved | 2020-01-24 | 2020-02-26 | 104353 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Resolved | 2023-06-19 | 2023-07-12 | 195459 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2020-07-16 | 2020-07-23 | 120500 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2024-06-07 | 2024-06-27 | 229936 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2020-04-16 | 2020-04-23 | 112382 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Resolved | 2022-10-17 | 2023-07-12 | 172018 |
| TEVA-FUROSEMIDE | 80MG | TABLET | Resolved | 2023-06-08 | 2023-06-21 | 194077 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Resolved | 2017-04-03 | 2017-05-23 | 5197 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42651 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2020-08-20 | 2020-12-17 | 122685 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2020-04-03 | 2020-04-23 | 110779 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Resolved | 2023-10-19 | 2024-01-11 | 207497 |
| TEVA-FUROSEMIDE | 80MG | TABLET | Resolved | 2020-01-24 | 2020-02-13 | 104347 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Resolved | 2023-07-20 | 2023-10-03 | 199284 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2020-02-21 | 2020-03-05 | 106913 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Resolved | 2023-02-09 | 2023-06-09 | 184174 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64861 |
| TEVA-ENALAPRIL | 16MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64866 |
| TEVA-FAMOTIDINE | 20MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81371 |
| TEVA-FINGOLIMOD | 0.5MG | CAPSULE | Discontinued | 2025-03-20 | 2025-03-20 | 253186 |
| TEVA-FLUCONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256137 |
| TEVA-FLUCONAZOLE | 100MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256091 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14042 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| TEVA-HALOPERIDOL | 20MG | TABLET | Discontinued | 2019-10-25 | 2019-10-26 | 97270 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106158 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64970 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106164 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106161 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64975 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64983 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231580 |
| TEVA-IRBESARTAN HCTZ | 300MG 12.5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231577 |